Palisade Bio Inc. buy Brookline Capital Management
Start price
13.05.25
/
50%
€0.34
Target price
13.05.26
€14.40
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.05.26. The prediction end date can be changed by Brookline_Capital_Ma at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Palisade Bio Inc. | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Palisade Bio Inc. diskutieren
Palisade Bio, Inc. (NASDAQ: PALI) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $16.00 price target on the stock.
Ratings data for PALI provided by MarketBeat